ECCT
Electro-Capacitive Cancer Therapy — a non-contact electric-field treatment that disrupts cancer cell division from outside the body, worn as apparel during everyday life.
ECCT is a non-contact electric-field treatment for cancers, built on the electrical capacitance technique. Capacitance electrodes embedded in a wearable apparel generate a modulated field around the tumour — no incision, no current passing into the body.
It was originally developed to support end-stage patients who had exhausted conventional options (around 57% of cases) or who use it alongside ongoing conventional treatment (around 37%). Ethical clearance was granted in 2012. The physical selectivity mechanism: the electrically charged protein structures forming the mitotic spindle interact with sub-300 kHz fields in ways determined by the cell's membrane potential and division rate — cancer cells, dividing faster with altered membrane potentials, are preferentially disrupted. In vitro studies confirmed reduced proliferation in MCF-7 breast cancer cell lines. Murine in vivo studies showed inhibited tumour growth alongside cytokine changes indicating modulation of the tumour immune microenvironment. Clinically: Akayama's Japan-based programme and Kaplan's oncology research together cover more than 5,000 patients across glioblastoma, breast, liver, and cervical cancers.
What happens at the cellular level.
Generate the field
An electric field with a specific modulation — intensity and frequency pattern — is shaped across the targeted tumour area.
Disrupt mitosis
During cell division, a splitting cell is highly polarised. The external field — below 300 kHz — interferes with the electrically charged protein structures forming the mitotic spindle (Abdulhakim Coskun, Biophysicist, Georgia Institute of Technology). Cancer cells with elevated division rates and altered membrane potentials are preferentially disrupted; normal tissue, dividing far more slowly, is largely unaffected.
Trigger self-destruction
Uneven chromosome division leads to mitotic arrest and apoptosis — the cell self-destructs. More polar, elastic, and higher-grade cells respond faster.
The device and its usage
Worn as apparel, during ordinary days.
A set of capacitance electrodes is embedded in a wearable apparel device. It runs on low voltage — under ±15 volts — powered by light batteries, so the patient can wear it during daily activities.
Treatment time is short compared with other electrical methods: typically 5–15 minutes, twice per day. A blanket-style apparel extends the approach to whole-body treatment for metastatic cancer.
Where ECCT applies
ECCT is most suited to malignant cancers with small metastatic lesions that are inoperable or resistant to chemotherapy and radiation — smaller lesions have a larger relative surface area and discharge faster.
Small metastatic lesions
Lesions not applicable for surgery respond well: dead cells discharge through nearby ducts and veins. Highly polarized types (Type B) clear in 3–6 months; less-polarized types may take longer.
Bone, liver, lung & brain spread
Good responses observed across metastatic breast cancer cases. Complete recovery remains possible when vital organs are relatively undamaged; otherwise ECCT is beneficial for palliative pain management.
Interbrain & brainstem tumours
For tumours that are unresectable, location matters less for soft, highly polarized types. ECCT can offer advantages for many inoperable tumours of the interbrain and midbrain.
Soft, polarized adenocarcinomas
Lung adenocarcinomas are typically soft and highly polarized — well suited to ECCT, with complete removal possible without surgery. Newer systems shorten treatment and leave less fibrosis.
It began with one sister.
Dr. Warsito P. Taruno first developed ECCT in 2010 to help his sister, Mrs. Suwarni, fight stage-4 breast cancer diagnosed in late 2009. After a mastectomy she declined chemotherapy and received no other treatment.
Following a promising cell study, Dr. Warsito built the first battery-powered ECCT system for her as an alternative. She reached remission after two months of wearing the device, and recovered again each of the three times the cancer recurred over three years.
More than ten years on, she lives free of cancer in normal condition.
Medical Physics & Cancer Research
The physical basis for ECCT — how sub-300 kHz capacitive fields interact selectively with dividing cancer cells, and the research record from Coskun's biophysics through Akayama and Kaplan's clinical programmes.
Monitored with ECVT
The ECVT Healthcare System images the electrical activity of tissue, letting clinicians watch lesions respond as ECCT treatment progresses — radiation-free.
Interested in ECCT?
Talk to our team about the technology, clinical research, and collaboration.
Get in Touch →ECCT is an investigational therapy under clinical study. Information here describes CTECH Labs' research and development and is not a medical claim or a substitute for professional medical advice.